Brian Sheng is an American businessman and investor with a distinguished career in Sino-US market opportunities. He is the Founder and CEO of Asia Horizon, a private equity investment, and operating company focused on the emerging hemp-derived cannabinoid industry in Asia.
Mr. Sheng’s track record includes serving as General Partner at The Arcview Group, Co-Founder and Managing Partner of Fresh VC, Foreign Investment Advisor at Qianhai URI Investment Fund, and serving as a Board Member for Eaze and FND Technologies.
Mr. Sheng has originated and executed transactions in water technology, government technology, and frontier sectors across North America and Asia-Pacific. He has been involved in early-stage venture capital, cross-border deals, and joint ventures, some of which include Eaze, FND Technology, Anderson Leonard Pharmaceuticals, FiscalNote, and Clever Leaves (f.k.a Northern Swan). He continues to be interested in US-Sino relations and aims to expand inter-market access with world-class companies that change the lives of millions of people.